Long intergenic non-protein coding RNA 1613 (LINC01613)

Long intergenic non-protein coding RNA 1613 (LINC01613) is a member of the *long intergenic non-coding RNA* (lincRNA) family, defined as autonomously transcribed non-coding RNAs longer than 200 nucleotides that do not overlap with annotated protein-coding genes[1][3][5]. LincRNAs are known for their regulatory potential, including remodeling chromatin architecture, modulating transcription in both sequence-dependent and -independent manners, stabilizing RNA, and sometimes exhibiting enhancer-associated functions[3]. The specific biological function and disease associations of LINC01613 itself remain uncharacterized in current databases and the biomedical literature, but lincRNAs as a class are recognized for tissue-specific expression patterns and for contributing to the regulation of neighboring gene activity and diverse gene regulatory processes, sometimes in the context of cancer[3][7]. There is no current evidence that LINC01613 is druggable, serves as a direct therapeutic target (such as a receptor, enzyme, transporter), or has validated biomarker or safety roles reported in disease.

Other names

LINC01613n341773